Cargando…

Enhanced Taste Recognition Following Subacute Treatment With The Dopamine D2/D3 Receptor Agonist Pramipexole in Healthy Volunteers

BACKGROUND: Patients with Parkinson’s disease (PD) show impaired performance in taste recognition tests, which suggests a possible dopaminergic influence on gustatory functioning. To experimentally test this hypothesis, we assessed whether pharmacological manipulation of dopaminergic signaling in he...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaltenboeck, Alexander, Halahakoon, Don Chamith, Harmer, Catherine J, Cowen, Philip, Browning, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Regular Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515131/ https://www.ncbi.nlm.nih.gov/pubmed/35605609 http://dx.doi.org/10.1093/ijnp/pyac030

Ejemplares similares

An Experimental Medicine Investigation of the Effects of Subacute Pramipexole Treatment on Emotional Information Processing in Healthy Volunteers
por: Martens, Marieke Annie Gerdine, et al.
Publicado: (2021)

Occupancy of pramipexole (Sifrol) at cerebral dopamine D2/3 receptors in Parkinson's disease patients
por: Deutschländer, Angela, et al.
Publicado: (2016)

Pramipexole, a dopamine D3/D2 receptor-preferring agonist, attenuates reserpine-induced fibromyalgia-like model in mice
por: Martins, Carlos Pereira, et al.
Publicado: (2021)

No antidepressant-like acute effects of bright light on emotional information processing in healthy volunteers
por: Kaltenboeck, Alexander, et al.
Publicado: (2021)

Pramipexole Increases Go Timeouts but Not No-go Errors in Healthy Volunteers
por: Yang, Xue Qing, et al.
Publicado: (2016)

Reward-Processing Behavior in Depressed Participants Relative to Healthy Volunteers: A Systematic Review and Meta-analysis
por: Halahakoon, D. Chamith, et al.
Publicado: (2020)

The D2 antagonist sulpiride modulates the neural processing of both rewarding and aversive stimuli in healthy volunteers
por: McCabe, Ciara, et al.
Publicado: (2011)

Chronic exposure to dopamine agonists affects the integrity of striatal D(2) receptors in Parkinson's patients
por: Politis, Marios, et al.
Publicado: (2017)

The Efficacy of Pramipexole, a Dopamine Receptor Agonist, as an Adjunctive Treatment in Treatment-Resistant Depression: An Open-Label Trial
por: Hori, Hiroaki, et al.
Publicado: (2012)

Dopamine transporter binding in symptomatic controls and healthy volunteers: Considerations for neuroimaging trials
por: Honkanen, Emma A., et al.
Publicado: (2021)

Baseline Perfusion Alterations Due to Acute Application of Quetiapine and Pramipexole in Healthy Adults
por: Michels, Lars, et al.
Publicado: (2016)

A Neurofunctional Domains Approach to Evaluate D1/D5 Dopamine Receptor Partial Agonism on Cognition and Motivation in Healthy Volunteers With Low Working Memory Capacity
por: Balice-Gordon, Rita, et al.
Publicado: (2020)

A Dissociation of the Acute Effects of Bupropion on Positive Emotional Processing and Reward Processing in Healthy Volunteers
por: Walsh, Annabel E. L., et al.
Publicado: (2018)

PAX-D: study protocol for a randomised placebo-controlled trial evaluating the efficacy and mechanism of pramipexole as add-on treatment for people with treatment resistant depression
por: Au-Yeung, Sheena Kristine, et al.
Publicado: (2022)

Altered Pain Processing Associated with Administration of Dopamine Agonist and Antagonist in Healthy Volunteers
por: Martin, Sarah L., et al.
Publicado: (2022)

Direct effects of diazepam on emotional processing in healthy volunteers
por: Murphy, S. E., et al.
Publicado: (2008)

Low dose pramipexole is neuroprotective in the MPTP mouse model of Parkinson's disease, and downregulates the dopamine transporter via the D(3 )receptor
por: Joyce, Jeffrey N, et al.
Publicado: (2004)

Binding of Pramipexole to Extrastriatal Dopamine D(2)/D(3) Receptors in the Human Brain: A Positron Emission Tomography Study Using (11)C-FLB 457
por: Ishibashi, Kenji, et al.
Publicado: (2011)

The D2-like Dopamine Receptor Agonist Quinpirole Microinjected Into the Ventral Pallidum Dose-Dependently Inhibits the VTA and Induces Place Aversion
por: Peczely, Laszlo, et al.
Publicado: (2022)

Predicting Treatment Response in Depression: The Role of Anterior Cingulate Cortex
por: Godlewska, Beata R, et al.
Publicado: (2018)

Human perceptual learning is delayed by the N-methyl-D-aspartate receptor partial agonist D-cycloserine
por: Dempsey-Jones, Harriet, et al.
Publicado: (2021)

Cognitive mechanisms of diazepam administration: a healthy volunteer model of emotional processing
por: Pringle, A, et al.
Publicado: (2016)

Dopamine D2/D3 receptor abnormalities after traumatic brain injury and their relationship to post-traumatic depression
por: Jolly, Amy E., et al.
Publicado: (2019)

Levodopa Versus Dopamine Agonist after Subthalamic Stimulation in Parkinson's Disease
por: Picillo, Marina, et al.
Publicado: (2020)

Dopaminergic agonist pramipexole improves memory and increases IL-10 production in LPS-challenged rats
por: Mihaylova, Anita, et al.
Publicado: (2021)

Dopamine-Depleted Dopamine Transporter Knockout (DDD) Mice: Dyskinesia with L-DOPA and Dopamine D1 Agonists
por: Pogorelov, Vladimir M., et al.
Publicado: (2023)

Dopamine agonist treatment increases sensitivity to gamble outcomes in the hippocampus in de novo Parkinson’s disease
por: van der Vegt, Joyce P.M., et al.
Publicado: (2020)

Efficacy of low-dose D(2)/D(3) partial agonist pramipexole on neuroleptic-induced extrapyramidal symptoms and symptoms of schizophrenia: a stage-1 open-label pilot study
por: Weng, Jia Jun, et al.
Publicado: (2019)

Pramipexole use and the risk of pneumonia
por: Ernst, Pierre, et al.
Publicado: (2012)

Healthy Volunteer 2020: Comparing Peace Corps Volunteers' health metrics with Healthy People 2020 national objectives()
por: Henderson, Susan J., et al.
Publicado: (2016)

Successful treatment of dopamine dysregulation syndrome with dopamine D(2) partial agonist antipsychotic drug
por: Mizushima, Jin, et al.
Publicado: (2012)

Pramipexole: new use for an old drug – the potential use of pramipexole in the treatment of restless legs syndrome
por: Benbir, Gulcin, et al.
Publicado: (2006)

Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers
por: Schmidt, Kristin, et al.
Publicado: (2014)

Pramipexole Impairs Stimulus-Response Learning in Healthy Young Adults
por: Gallant, Haley, et al.
Publicado: (2016)

The effects of atorvastatin on emotional processing, reward learning, verbal memory and inflammation in healthy volunteers: An experimental medicine study
por: De Giorgi, Riccardo, et al.
Publicado: (2021)

Burning mouth syndrome responsive to pramipexol
por: Stuginski-Barbosa, J., et al.
Publicado: (2008)

Automatic behavior and communication due to pramipexole
por: Walker, Ruth H.
Publicado: (2016)

Ligand recognition and biased agonism of the D1 dopamine receptor
por: Teng, Xiao, et al.
Publicado: (2022)

The Roles of Dopamine D1 Receptor on the Social Hierarchy of Rodents and Nonhuman Primates
por: Yamaguchi, Yoshie, et al.
Publicado: (2016)

Dopamine D(1) and D(3) Receptors Modulate Heroin-Induced Cognitive Impairment through Opponent Actions in Mice
por: Zhu, Yongsheng, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_tk0omre1t2ovn04e1qfv8b4fqt